BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    BINAXNOW COVID-19 AG SELF TEST 2CT

    MDR report key: 16760855 · Received April 18, 2023

    Report

    Report Number
    1221359-2023-00636
    Event Type
    Malfunction
    Date Received
    April 18, 2023
    Date of Event
    April 4, 2023
    Report Date
    May 26, 2023
    Manufacturer
    ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
    Product Code
    QKP
    UDI-DI
    00811877011408
    PMA / PMN Number
    EUA210264
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    003

    Narratives

    Additional Manufacturer Narrative · 0

    THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION. H3 OTHER TEXT: SINGLE USE; DEVICE DISCARDED.

    Additional Manufacturer Narrative · 0

    INVESTIGATION CONCLUSION TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 225141 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160 / LOT 225141, TEST BASE PART NUMBER 195-430WJR / LOT 222477. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 225141 SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS SCARBOROUGH, INC. WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER, IT COULD HAVE BEEN RELATED TO THE SPECIFIC PATIENT SAMPLE.CORRECTED: A1 H3 OTHER TEXT : SINGLE USE; DEVICE DISCARDED.

    Description of Event or Problem · 0

    THE CONSUMER REPORTED TWO (2) FALSE NEGATIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST FOR MULTIPLE TESTS. THIS MFR. REPORT ADDRESSES TEST ONE (1) OF TWO (2). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2023 ON AN UNKNOWN SAMPLE TYPE. CONFIRMATION TESTING (UNKNOWN PLATFORM) WAS PERFORMED AT A HOSPITAL ON (B)(6) 2023 AND GENERATED A POSITIVE RESULT. THE CONSUMER WAS SYMPTOMATIC AND ADVISED BY HER HEALTHCARE PROVIDER TO MEDICATE AND ISOLATE FOR FIVE (5) DAYS.

    Description of Event or Problem · 0

    THE CONSUMER REPORTED TWO (2) FALSE NEGATIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST FOR MULTIPLE TESTS. THIS MFR. REPORT ADDRESSES TEST ONE (1) OF TWO (2). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2023 ON AN UNKNOWN SAMPLE TYPE. CONFIRMATION TESTING (UNKNOWN PLATFORM) WAS PERFORMED AT A HOSPITAL ON (B)(6) 2023 AND GENERATED A POSITIVE RESULT. THE CONSUMER WAS SYMPTOMATIC AND ADVISED BY HER HEALTHCARE PROVIDER TO MEDICATE AND ISOLATE FOR FIVE (5) DAYS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1187523 BINAXNOW COVID-19 AG SELF TEST 2CT CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 225141 00811877011408

    Patients

    Seq Age Sex Outcome Treatment
    1 Female